Relief of dyspnoea by β2-agonists after methacholine-induced bronchoconstriction

Respiratory Medicine

Volumn 98, Issue 9, 2004, Pages 816-820

  van der Woude, Hanneke J ^a   Postma, Dirkje S ^b   Politiek, Mathijs J ^a   Winter, Trea H ^a   Aalbers, René ^a  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Asthma; Borg score; Dyspnoea; Formoterol; Salbutamol; Salmeterol

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FORMOTEROL; METHACHOLINE; PLACEBO; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; DRUG DERIVATIVE; ETHANOLAMINE DERIVATIVE; METHACHOLINE CHLORIDE;

ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; ADOLESCENT; ADULT; DRUG EFFECT; FEMALE; MALE; NEBULIZER; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPNEA; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; NEBULIZERS AND VAPORIZERS; TIME FACTORS;

EID: 4043096372     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.03.001     Document Type: Article

References (14)

1. Global initiative for Asthma (GINA). Global strategy for asthma management and prevention. Washington, DC: National Institutes of Health, National Heart Lung and Blood institute; 2002. Publication No. 02-3659.
2. Osman L.M. McKenzie L. Cairns J. et al. Patient weighting of importance of asthma symptoms Thorax 56 2001 138-142
3. Van Schayck C.P. Van der Heijden F.M.M.A. Van den Boom G. Tirimanna P.R.S. Van Herwaarden C.L.A. Under diagnosis of asthma: is the doctor or the patient to blame. The DIMCA project Thorax 55 2000 562-565
4. Bender B.G. Overcoming barriers to nonadherence in asthma treatment J Allergy Clin Immunol 109 2002 S534-S539
5. Pearlman D.S. Chervinsku P. LaForce C. et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma N Engl J Med 327 1992 1420-1425
6. Kesten S. Chapman K.R. Broder I. et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma Am Rev Respir Dis 144 1991 622-625
7. Politiek M.J. Boorsma M. Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction Eur Respir J 13 1999 988-992
8. Quanjer P.H.H. Tammeling G.J. Cotes J.E. Pederson O.F. Peslin R. Yernault J.C. Lung volumes and forced ventilatory flows. Report working party: standardisation of lung function tests. European Community for steel and coal. Official statement of the European Respiratory Society Eur Respir J 6 suppl.16 1993 5-40
9. Wilson R.C. Jones P.W. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise Clin Sci 76 1989 277-282
10. 2-agonists improve the perception of bronchoconstriction in asthma Am J Respir Crit Care Med 164 2001 764-769
11. Bijl-Hofland I.D. Folgering H.T.M. Van den Hoogen H. et al. Perception of bronchoconstriction in asthma patients measured during histamine challenge test Eur Respir J 14 1999 1059-1064
12. Burdon J.G.W. Juniper E.F. Killian J. Hargreave F.E. Campbell E.J.M. The perception of breathlessness in asthma Am Rev Respir Dis 126 1982 825-828
13. Kendrik K.R. Baxi S.C. Smith R.M. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and Asthma J Emerg Nurs 26 2000 216-222
14. Killian K.J. Measurements of dyspnoea during bronchoconstriction Eur Respir J 13 1999 943-946